Search results
Rhythm Pharma's Setmelanotide Shows Encouraging Action In Hypothalamic Obesity Study
Benzinga via Yahoo Finance· 2 years agoRhythm Pharmaceuticals Inc (NASDAQ: RYTM) announced interim results from a Phase 2 trial of...
Rhythm Pharmaceuticals Inc (RYTM) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 6 months agoRhythm Pharmaceuticals Inc (NASDAQ:RYTM) reported a net revenue of $22.5 million from global sales...
Rhythm (RYTM) Surges on Upbeat Data on Lead Product Candidate
Zacks via Yahoo Finance· 2 years agoRhythm Pharmaceuticals (RYTM) reports favorable data from a mid-stage study evaluating the efficacy...
Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition
Benzinga via Yahoo Finance· 2 years agoRhythm Pharmaceuticals Inc (NASDAQ: RYTM) announced that over 35 physicians have written 50+...
Rhythm Pharmaceuticals, Inc. (RYTM) Surges 42.2%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 2 years agoRhythm Pharmaceuticals, Inc. (RYTM) witnessed a jump in share price last session on above-average...
Biotech Stock Roundup: MRNA's Jab Update, ACER Down on Regulatory News & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week with important pipeline and regulatory...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript February 22, 2024 Rhythm...
Rhythm Pharma Secures Non-Dilutive Financing Of $100M To Use Of This...
Benzinga via Yahoo Finance· 2 years agoRhythm Pharmaceuticals Inc (NASDAQ: RYTM) entered into a Revenue Interest Financing Agreement with...
What's the difference between Ozempic and Zepbound? Our comprehensive guide to weight-loss drugs
Yahoo Life Style via AOL· 5 months agoNew weight-loss drugs have marked "the start of a new era" in the treatment of excess weight and...
Insider Sell Alert: Joseph Shulman of Rhythm Pharmaceuticals Inc Cashes Out Shares
GuruFocus.com via Yahoo Finance· 6 months agoIn the realm of biopharmaceuticals, insider transactions are often scrutinized for insights into the...